Cite
HARVARD Citation
Xie, Y. et al. (2022). Heterogeneity derived from 18F‐FDG PET/CT predicts immunotherapy outcome for metastatic triple‐negative breast cancer patients. Cancer medicine. pp. 1948-1955. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xie, Y. et al. (2022). Heterogeneity derived from 18F‐FDG PET/CT predicts immunotherapy outcome for metastatic triple‐negative breast cancer patients. Cancer medicine. pp. 1948-1955. [Online].